Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Rare Diseases – An Evolving Medical Communications Landscape
A disease is considered rare when it affects fewer than 1 in 2,000 people. However...
Celebrating Health Literacy Month 2024: Strengthening Biopharma-Patient Connections
October is Health Literacy Month, a reminder of the importance of clear communication in healthcare...
Celebrating World Patient Safety Day 2024: Improving Diagnosis for a Safer Tomorrow
On World Patient Safety Day 2024, we focus on the critical theme of "Improving Diagnosis...
How to Incorporate and Drive Equity, Diversity, and Inclusion in Medical Communications and Publications
A roadmap on how to drive advocacy for EDI in medical communications and publications and...
3 Factors That Will Help Pharma Build Public Trust
Pharma must engage with patients at all levels to build public trust...
Role of Scientific Communication and Medical Professionals in Combating Vaccine Hesitancy
Read an insightful discussion from the latest ISMPP conference on how science communication and medical...
- 1
- 2